Novirio Pharmaceuticals Limited Becomes Idenix Pharmaceuticals , Inc.


CAMBRIDGE, Mass., May 29, 2002 - Novirio Pharmaceuticals Limited, a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced that the company has changed its name to Idenix Pharmaceuticals, Inc. The new name, Idenix, is intended to reflect the application of its drug discovery expertise and development experience in the areas of hepatitis B, hepatitis C and HIV and the potential application of this expertise and experience to the treatment of other infectious diseases.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionising chemistry?